(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Earnings In Focus: Gilead Sciences, Uber, and Lucid Group Gear Up

  • November 04th, 2023
  • 503 views

On Tuesday, November 7, several significant companies are slated to unveil their financial results, including:

Gilead Sciences, Inc. (Nasdaq: GILD), a leading biopharmaceutical company, will release its third-quarter 2023 financial results and guidance after the market closes.

Market consensus suggests earnings per share (EPS) of $1.91 on revenue amounting to $6.79 billion.

$GILD closed at $81.59 on Friday, showing an increase of $0.36 (+0.44%).

Uber Technologies, Inc. (NYSE: UBER), a major player in the ride-hailing and food delivery industry, is set to report its third-quarter 2023 financial results before the market opens.

Analysts anticipate an EPS of $0.11 on revenue totaling $8.99 billion.

On Friday, $UBER closed at $47.75, up $1.27 (+2.73%).

Lucid Group, Inc. (Nasdaq: LCID), an electric vehicle manufacturer, will report its third-quarter 2023 financial results following the market's closure.

The consensus estimate points to a loss of $0.35 per share, accompanied by revenue reaching $192.72 million.

$LCID closed at $4.62 on Friday, reflecting a gain of $0.08 (+1.76%).

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13